Lars Boesen

MD, PhD, DMSci, Associate Professor, Urology, Copenhagen University Hospital

[Jim Hu @jimhumd]

0 TP infections without antibiotic prophylaxis vs 1.6% TR infections with targeted prophylaxis (p=0.02). No difference in cancer detection 55% vs 52% for TP vs TR.

[Lars Boesen @BoesenLars]

For link to related paper:

https://t.co/Iq8vDpoNna

[KOELIS @KoelisBx]

Dr Nis Norgaard, urologist from Herlev hospital in Copenhagen (Denmark) shares his experience concerning the switch from transrectal to #transperineal approach for #prostatebiopsy. Discover the interview:
https://t.co/7ELkps17qO

[KOELIS @KoelisBx]

Dr Nis Norgaard, urologist from Herlev hospital in Copenhagen (Denmark) shares his experience concerning the switch from transrectal to #transperineal approach for #prostatebiopsy. Discover the interview:
https://t.co/7ELkps17qO

[Lars Boesen @BoesenLars]

Great Prostate MRI course now coming to DK💪

[Vibeke Løgager @vbloegager]

Reserve the date May 28th 2024
more Prostate MRI !
https://t.co/I4Vh2PkijB

[Lars Boesen @BoesenLars]

@PeterBOstergren @vbloegager @Uroweb @RBisbjerg @HerlevGentofte @DCCCcancer @UrologiDK @Urologi @KoelisBx Thanks Peter, very kind🙏, likewise… it’s a team effort🤛

[Lars Boesen @BoesenLars]

After years of preparation and phantom-training, I am so happy to share that the first two Danish patients with prostate cancer yesterday was treated successfully with MRI-ultrasound fusion focal targeted brachytherapy in Dept. of Urology @HerlevGentofte in the CAPFIRE study🎯🔥

[Lars Boesen @BoesenLars]

#personalizedtreatment #multidisciplinaryapproach #firstdonoharm
@vbloegager @PeterBOstergren @Uroweb @RBisbjerg @HerlevGentofte @DCCCcancer @UrologiDK @urologi @KoelisBx

[Lars Boesen @BoesenLars]

This is a true personalized treatment effort in a multidisciplinary team setting incl. Urology, Radiology, and Oncology together with industrial software development @KOELIS. Thanks to all involved and our leaders for supporting research innovation and development. 🙏💪

[Lars Boesen @BoesenLars]

We confirm that the procedure is well tolerated and has a very low risk of side effects
@vbloegager @RBisbjerg @HerlevGentofte @EurUrolOpen

[Lars Boesen @BoesenLars]

I'm happy to share our 1st year clinical experience completely transitioning from office-based transrectal to transperineal Bx under LA without the use of any profylactic antibiotics despite possible risk factors such as IDC, recent UVI or DM.

https://t.co/3S3emtM5cL

[Michael Hofman @DrMHofman]

🔍 Exciting News from #PRIMARY2: A Landmark 660-Patient 🇦🇺 RCT

📖Protocol online: https://t.co/XMJ188ynsH

👥 295 randomised📈

🤝 Proud Collaboration:
@ButeauJames
@drlouiseemmett
@DrDanielMoon
@declangmurphy
@DrDavePattison
@mfrydenberg
@szetinglee1

💰 @PCF_Science

[COMPASS Research Group · UCL 🧭 @COMPASSurology]

⛳️ This week we are excited to announce 📢 the recent milestones of our French 🇫🇷 and Denmark 🇩🇰 sites for #PRIME recruitment ‼️✨

🌟 @Sorbonne_Univ_: 5️⃣➕
🌟 @HerlevGentofte: 3️⃣➕

#UroSoMe #prostatecancer #prostateMRI

[Lars Boesen @BoesenLars]

@dr_coops @DanLinMD @lawrentschuk High risk in nomogram - We use Briganti 2018

[Andrew Vickers @VickersBiostats]

More evidence if a prostate cancer is hard to find, it probably isn't that aggressive. If GG1 on initial biopsy, but upgraded on confirmatory, risk is much lower than GG2 or 3 on initial.

[COMPASS Research Group · UCL 🧭 @COMPASSurology]

A thought-provoking 💡 and inspirational ✨ meeting with the #PRIME investigators at #EAU23 🙌🏽

🤔 Building on last year's ideas🌍
🤔 Discussion of new ideas 🌑
🤔 Collaboration with brilliant international minds 🧠

@Uroweb @ESRUrology @EAUYAUrology @EAUrf @eau_yuo #UroSoMe

[Vibeke Løgager @vbloegager]

Looking forward to contributing with our team @BoesenLars @HerlevGentofte @KayalvilyNiels1

[JAMA Network Open @JAMANetworkOpen]

The surveillance rate for low-risk #ProstateCancer has risen from 27% to 60%, 2014-2021, but overtreatment remains common, with substantial local variation. @dr_coops @dannymak #pcsm @amerurological Quality AQUA Registry https://t.co/uMVC4oxYLc

[Lars Boesen @BoesenLars]

@arvinkgeorge @UMichUrology @brady_urology Congrats Arvin💪

[Caroline Moore @mrsprostate]

An honour to lead this - huge expertise from the lived experience and healthcare professional Recommendations for current AS practice (no DRE if doing MRI, consider omitting biopsy if MRI and PSA stable) and future research priorities - risk adapted approaches. More work to come!

[Dept. of Molecular Medicine @moma_dk]

Glad for at være vært for det første møde i Dansk Prostatakræft Konsortium https://t.co/7aFTzu7k0Q, et nationalt samarbejde for bedre og tidligere diagnose af #prostatakræft.
DPCC-1 er støttet af @novonordiskfond.

@MichaelBorre3 @DalsgaardKarina @JacobFredsoe